Abrogation of the interaction between osteopontin and αvβ3 integrin reduces tumor growth of human lung cancer cells in mice
- 30 September 2007
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 57 (3), 302-310
- https://doi.org/10.1016/j.lungcan.2007.03.019
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435Clinical & Experimental Metastasis, 2006
- Endostatin gene transfer in murine lung carcinoma cells induces vascular endothelial growth factor secretion resulting in up-regulation of in vivo tumorigenecityCancer Letters, 2006
- Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor PerfusionClinical Cancer Research, 2005
- Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasisCarcinogenesis: Integrative Cancer Research, 2005
- Tumor angiogenesis of non–small cell lung cancerMicroscopy Research and Technique, 2003
- Osteopontin expression in lung cancerLung Cancer, 1996
- Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)Science, 1996
- Angiogenesis inhibition: A reviewPharmacology & Therapeutics, 1994